Hunter C Smith's Net Worth
$5.8 Million
Who is Hunter C Smith?
Hunter C Smith has an estimated net worth of $5.8 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., Aeglea BioTherapeutics, Inc., and GENESEE & WYOMING INC.
SEC CIK
Hunter C Smith's CIK is 0001636385
Past Insider Trading and Trends
2023 was Hunter C Smith's most active year for acquiring shares with 10 total transactions. Hunter C Smith's most active month to acquire stocks was the month of January. 2023 was Hunter C Smith's most active year for disposing of shares, totalling 14 transactions. Hunter C Smith's most active month to dispose stocks was the month of January. 2023 saw Hunter C Smith paying a total of $357,760.00 for 2,081,707 shares, this is the most they've acquired in one year. In 2019 Hunter C Smith cashed out on 24,824 shares for a total of $1,324,288.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $47.8
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -13.68% | -15.52K |
$39.22 | -$608,498.30 | 97.94K |
Mar 19
| |||
Form 4
| +42.34% | 33.75K |
—
|
—
| 113.45K |
Feb 16
| |||
Form 4
| +5.97% | 4.49K |
$50.80 | -$97,440.80 | 79.7K |
Feb 9 - Feb 13
| |||
Form 4
| +4.60% | 3.31K |
$45.06 | -$72,816.96 | 75.22K |
Feb 1
| |||
Form 4
| +17.10% | 10.5K |
$6.88 | $72,240.00 | 71.91K |
Dec 29
| |||
Form 4
|
—
|
0
|
$22.80 | -$860,420.78 | 61.41K |
Dec 5 - Dec 6
| |||
Form 4
|
—
|
0
|
$20.95 | -$308,834.70 | 61.41K |
Nov 24
| |||
Form 4
|
—
|
0
|
$18.63 | -$282,013.20 | 61.41K |
Nov 14
| |||
Form 4
| +3.37% | 2K |
$6.88 | $13,760.00 | 61.41K |
Jun 16
| |||
Form 4
| +2.84% | 1.64K |
$26.87 | -$18,862.74 | 59.41K |
Scheduled
|
Feb 11 - Feb 14
| ||
Form 4/A
| -2.39% | -1.41K |
$27.51 | -$38,871.63 | 57.76K |
Scheduled
|
Feb 9
| ||
Form 4
| +4.84% | 2.67K |
$27.66 | -$38,668.68 | 57.78K |
Scheduled
|
Feb 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| -4.34% | -2.50K |
—
|
—
| 55.11K |
Dec 23
| |||
Form 4
| +43.46% | 17.45K |
$4.08 | -$30,791.76 | 57.61K |
Scheduled
|
Jun 30 - Jul 1
| ||
Form 4
| +3.91% | 1.51K |
$6.10 | -$5,081.30 | 40.16K |
Scheduled
|
Feb 11 - Feb 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
| +14.86% | 5K |
$6.88 | $34,400.00 | 38.65K |
Apr 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
| +13.49% | 4K |
$6.88 | $27,520.00 | 33.65K |
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
| +15.15% | 3.9K |
$6.88 | $26,832.00 | 29.65K |
Mar 30
| |||
Form 4
| +15.73% | 3.5K |
$6.88 | $24,080.00 | 25.75K |
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +39.06% | 6.25K |
$6.88 | $43,000.00 | 22.25K |
Jan 28
| |||
Form 4
| +166.67% | 10K |
$6.88 | $68,800.00 | 16K |
Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| +100.00% | 3K |
$6.88 | $20,640.00 | 6K |
Jan 31
| |||
Form 4
|
∞
| 3K |
$6.88 | $20,640.00 | 3K |
Sep 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aeglea BioTherapeutics, Inc. (AGLE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GENESEE & WYOMING INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -11.82K |
$112.00 | -$1,324,288.00 |
0
|
Dec 30
| |||
Form 4
| +1.42% | 166 |
$110.67 | $18,371.22 | 11.82K |
Sep 30
| |||
Form 4
| +2.70% | 307 |
$98.57 | $30,260.99 | 11.66K |
Jun 30
| |||
Form 4
| +11.39% | 1.16K |
$86.07 | $99,927.27 | 11.35K |
May 22
| |||
Form 4
| +2.94% | 291 |
$86.88 | $25,282.08 | 10.19K |
Mar 31
| |||
Form 4
| +3.41% | 326 |
$73.80 | $24,058.80 | 9.9K |
Dec 31
| |||
Form 4
| +2.67% | 249 |
$91.61 | $22,810.89 | 9.57K |
Sep 30
| |||
Form 4
| +2.52% | 229 |
$80.48 | $18,429.92 | 9.32K |
Jun 30
| |||
Form 4
| +16.69% | 1.3K |
—
|
—
| 9.1K |
May 23
| |||
Form 4
| +3.98% | 298 |
$70.14 | $20,901.72 | 7.79K |
Mar 31
| |||
Form 4
| +5.06% | 361 |
$78.72 | $28,417.92 | 7.5K |
Dec 31
| |||
Form 4
| +3.63% | 250 |
$73.53 | $18,382.50 | 7.13K |
Sep 30
| |||
Form 4
| +4.10% | 271 |
$67.83 | $18,381.93 | 6.88K |
Jun 30
| |||
Form 4
| +26.58% | 1.39K |
—
|
—
| 6.61K |
May 24
| |||
Form 4
| +5.45% | 270 |
$68.10 | $18,387.00 | 5.22K |
Mar 31
| |||
Form 4
| +7.69% | 354 |
$69.59 | $24,634.86 | 4.96K |
Dec 31
| |||
Form 4
| +7.15% | 307 |
$68.10 | $20,906.70 | 4.6K |
Sep 30
| |||
Form 4
| +9.29% | 365 |
$57.23 | $20,888.95 | 4.29K |
Jun 30
| |||
Form 4
| +67.69% | 1.59K |
—
|
—
| 3.93K |
May 17
| |||
Form 4
| +18.75% | 370 |
$63.30 | $23,421.00 | 2.34K |
Mar 31
| |||
Form 4
| +20.82% | 340 |
$54.08 | $18,387.20 | 1.97K |
Dec 31
| |||
Form 4
| +33.20% | 407 |
$57.51 | $23,406.57 | 1.63K |
Sep 30
| |||
Form 4
| +21.39% | 216 |
$76.62 | $16,549.92 | 1.23K |
Jun 30
| |||
Form 4
| +14,328.57% | 1K |
—
|
—
| 1.01K |
May 12
| |||
Form 4
|
∞
| 7 |
$97.19 | $680.33 | 7 |
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||